Patients should not discontinue statins in favour of GLP-1 therapy for cholesterol management without explicit guidance from their healthcare provider, as this could compromise cardiovascular risk reduction
This portal allows you to search specifically for Lilly-sponsored studies and may offer additional contact information for trial sites
Food and Drug Administration (FDA) This could include drugs such as semaglutide (the active ingredient in Ozempic and Wegovy), According to the FDAs announcement, the organization is asking for submitted comments for or against this decision by the end of June 2026 before making their final determination
Comparative efficacy and tolerability of currently approved incretin mimetics: a systematic analysis of placebo-controlled clinical trials
In this way, you will restrict the functionality of not only this website, but probably most sites
One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick
